Home/ Stocks/ CURX

Curanex Pharmaceuticals Inc Common Stock

CURX XNAS

$0.28 +0.01 (+2.67%) ▲ 15-min delayed

Open

N/A

High

N/A

Low

N/A

Volume

N/A

Market Cap

$7.94M

About Curanex Pharmaceuticals Inc Common Stock

Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 6 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$0	$-3,150,228	$-0.11
FY 2025	$0	$-4,225,106	$-0.17
Q3 2025	$0	$-954,059	$-0.04

TickerDaily Coverage

Why Is Curanex Pharmaceuticals Inc Common Stock (CURX) Stock Up 65.9% Today?

Penny Stocks Marcus Rivera · Feb 25, 2026

Curanex Pharmaceuticals Inc Common Stock (CURX) ripped 65.9% higher to $0.3155 on extraordinary...

View All Coverage →

Get CURX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Curanex Pharmaceuticals Inc Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.